Order Brochure
  
Proteonomix has filed a registration statement on Form 10 with the Securities and Exchange Commission.
Filings may be found at the following link:
http://www.sec.gov/cgi-bin/browse-edgar?company=Proteonomix&match=&CIK=&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
Proteonomix trades under the symbol PROT.PK

02.10.09: Proteonomix, Inc. (PROT) Announces Definitive Agreement for Sale of Its Stem Cell Derived Cosmeceutical Products With Two Companies Headquartered in China

01.15.09: International Business Times announces Proteonomix, Inc.(PROT) is "One to Watch"

01.05.09:Proteonomix, Inc.(PROT) announces the appointment of Steven Byle to its Board of Directors effective January 15, 2009.

12.15.08: Proteonomix, Inc. Announces the Publication of Research on Use of Umbilical Cord Blood in Growing Undifferentiated Embryonic Stem Cells

12.08.08:Proteonomix, Inc. Announces That Its Subsidiary, Proteoderm, Inc., Has Entered Into a Letter of Intent With Sinoquest Investment Limited for the Licensing, Purchase and Distribution of Proteoderm's Co.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
© Copyright 2009 PROTEONOMIX , Inc.
  Home | Who We Are | What We Do | PROTEONOMIX Cord Blood Bank | Product Development | Practitioners | Investor Information | News & Events | Careers | Contact